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ABSTRACT
INVESTIGATION OF THE ELECTROSTATIC INTERACTIONS OF THE T7
REPLISOME
Brittni M. Foster, Masters of Science in Chemistry
Western Carolina University (June 2016)
Advisor: Dr. Jamie R. Wallen
DNA replication is a process in which genetic information is copied and passed on from gen-
eration to generation. Multiple proteins of specialized function must transiently assemble
and communicate to rapidly and accurately copy DNA. We study replication in bacterio-
phage T7, a virus that infects Escherichia coli (E. coli), because it is a relatively simple
model system that recapitulates all essential activities seen in more complex systems in just
four proteins. Recently our laboratory determined a crystal structure of an electrostatic
interaction between T7 primase-helicase and DNA polymerase, and the structure revealed
the acidic C-terminal tail of the T7 primase-helicase binds to a basic patch on the surface of
the polymerase. The C-terminal tail of the primase-helicase contains a phenylalanine residue
that is essential for binding polymerase, and our structure reveals that this phenylalanine
binds to a hydrophobic cleft near the basic patch. Our crystal structure also unexpectedly
revealed an interaction between a nucleotide triphosphate and tryptophan 160 located in the
exonuclease active site, and this interaction has shed light on how the exonuclease domain
of T7 polymerase recognizes a DNA substrate. To validate our crystal structure, point mu-
tations were generated along the basic patch of the polymerase as well as the hydrophobic
pocket to disrupt the observed interactions.
viii
Using in vivo methods such as phage complementation and multi-step growth curve
we are able to directly test the effects on the virus replication during infection of E. coli.
Phage complementation results demonstrate that these mutations F487A, I569A, R687A and
R590A show a 3-log and 4-log difference in growth compared to WT. Plaque assay results
show that R590A is critical for replication, as the virus shows no growth under identical con-
ditions for WT. The other mutations I569A, I569A, and F487A were also impaired during
the plaque assay and similar to R590A showed no plaque formation. R687A showed substan-
tially smaller plaques compared to WT and we were unable to calculate a titer. No plaque
formation and smaller plaques indicate that the virus is heavily impaired in DNA replication.
Under identical conditions to WT, R590A show no growth over a 15 hour period where as
WT reaches a maximum amount of virus and plateaus at 4 hours. Preliminary data for
I569A and F487A show these mutations also result in impaired and reach a lower maximum
viral concentration compared to WT. In the crystal structure R590 of the polymerase makes
a critical contact with the C-terminal tail, and in agreement with the structure, mutation of
R590 to alanine suggests that this residue serves an essential function in DNA replication.
Phage complementation results for the two mutations in the exonuclease active site,
W160A and 5A7A, gave similar results compared to WT at a log of 1x1012 PFU/mL. The
double mutation D5A and E7A (5A7A) is unable to coordinate Mg+2 causing exonuclease
activity to be diminished. Results for rolling circle reveal that polymerase with a 5A7A
mutation can perform strand displacement synthesis without helicase. Future work will
focus on continuing Rolling circle, growth curve, and primer extension assays.
ix
CHAPTER 1 INTRODUCTION
1.1 MOTIVATION
DNA replication is a complex process requiring a coordinated system consisting of a multi-
tude of proteins. A simple organism such as the bacteria Escherichia coli(E. coli) needs 12
proteins to replicate their DNA while 40-50 human proteins are needed to accurately copy
both strands.3,4 Multiple proteins of specialized function must transiently assemble and com-
municate to rapidly and accurately copy DNA of all genomes. These proteins form a highly
coordinated machine called a replisome.5 If anything goes wrong during DNA replication,
mutations can occur, leading to numerous diseases. Due to the complexity of the human
replisome, many of the mechanisms for protein-protein interactions in the human system are
still unknown. Because of this, simpler replication systems are used as models.6 Bacterio-
phage T7, a virus that infects E. coli, is a model system that can recapitulate all essential
activities of DNA replication with only four proteins.1
This project brings understanding of how these four replication proteins interact not only
in T7 but also in higher organisms. An understanding of the T7 replisome will shed light on
essential interactions in replisomes of pathogenic bacteria. A study of the T7 system can pro-
vide a selective way to attack the replication system in pathogenic bacteria without adverse
effects to humans. Recently, a crystal structure was determined showing an electrostatic
interaction between the T7 primase-helicase C-terminal tail and the T7 DNA polymerase
(unpublished data from our lab). For DNA replication to occur these two proteins must
interact and the interaction between the C-terminal tail of the primase helicase and DNA
polymerase is essential. This project focuses on validating this specific electrostatic interac-
tion between the T7 DNA polymerase (pol) and the C-terminal tails of both the helicase and
single-stranded DNA binding proteins (SSB). Since the interaction between the SSB and the
1
pol is seen in both T7 and pathogenic bacterial DNA replication but is absent in humans,
this interaction could be targeted by therapeutics.7–9
1.1.1 DNA REPLICATION
To successfully replicate duplex DNA several events need to occur. The double stranded
DNA (dsDNA) must be unwound, primer synthesis needs occur to initiate lagging strand
synthesis, the antiparallel strands need to be identically copied, and an editing method needs
to be incorporated to make sure the correct nucleotides have been put in place. Figure 1
illustrates the synthesis of duplex DNA for the leading and lagging strands of DNA.5
Figure 1. An illustration of leading and lagging strand synthesis of duplex DNA.
Double stranded DNA is antiparallel in nature, and replisomes can only synthesize DNA
in one direction. DNA is unwound by a motor protein called a helicase. For T7 the C-
terminal helicase domain of the primase-helicase enzyme will unwind the DNA in the 5’→
3’ direction. As the DNA is being unwound both strands will be copied at the same time by
a DNA polymerase. In T7, the DNA polymerase synthesizes DNA in the 3’→ 5’ direction.
2
At least two polymerases are needed in the replisome to synthesize both leading and lagging
strands simultaneously. To overcome the antiparallel orientation of DNA the leading strand
is synthesized in short stretches (∼3,000 bases) called Okazaki fragments. To create the
Okazaki fragments the lagging strand needs to align its polarity with the leading strand
causing a replication loop to form.1 The lagging strand polymerase begins replication of the
discontinuous Okazaki fragments using RNA primers synthesized by the N-terminal primer
domain of the primase-helicase. The small fragments will later be joined by a DNA ligase.
The T7 polymerase has 3’→ 5’ exonuclease activity, making it able to check that the correct
nucleotides were put into place during replication.
1.2 T7 BACTERIOPHAGE
T7 is a lytic phage meaning that it destroys the host once it has sufficiently replicated its
genome and assembled new viral particles.10 T7 attaches to the host cell and injects its 40
kilobase (kb) genome that encodes approximately 50 proteins into the bacterial host.11 This
phage replicates its DNA using the four essential proteins, three of which are encoded from
its own genome and one that is hijacked from the host. These four proteins are coordinated
and act as one machine called a replisome.12 Each protein in the replisome has an essential
function; if any one of these proteins are missing, DNA will not be synthesized. Figure 2
shows the current model for how the four T7 proteins assemble to copy DNA. The first pro-
tein is the primase-helicase (purple circle). The N-terminal domain catalyzes RNA primer
synthesis needed to initiate DNA synthesis of the lagging strand, while the C-terminal he-
licase domain catalyzes nucleotide-dependent DNA unwinding. The second protein is the
DNA polymerase (green circle) that copies the DNA. Thioredoxin or Trx (yellow sphere
attached to the polymerase) binds to polymerase to aid in copying the DNA by increasing
its processivity (number of nucleotides that are copied in a single binding event). Trx is the
only protein not encoded in the T7 genome and is hijacked from the host E. coli.1 Poly-
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merase and thioredoxin are two separate proteins and they bind together to form a high
affinity complex (pol/trx) with a Kd of ∼5nM.13 The fourth protein is the single-stranded
DNA-binding protein (SSB, Orange circle). SSB binds and protects single stranded DNA as
well as interacts with both the helicase and polymerase to coordinate the replisome into a
single functional unit.1 It is important to note that both the primase-helicase and the SSB
have an acidic C-terminal tail that is represented by the red lines in Figure 2.
Figure 2. 1 The current model of the four T7 proteins working together to replicate DNA.
Circled in green is the polymerase, circled in orange is the single-stranded DNA binding
protein, circled in purple is the primase-helicase.
1.2.1 MODES OF REPLICATION
When replicating DNA, the primase-helicase and the polymerase have at least three modes of
binding known as the polymerization mode, the priming mode, and the electrostatic mode.1
The electrostatic mode is the only mode of binding that requires the electrostatic interaction
involving the acidic C-terminal tails of the helicase and SSB, and this is the mode that is
the focus of this project. The electrostatic interaction involves the highly acidic C-terminal
tails of helicase and SSB with the two basic patches of the polymerase (Figure 4).2
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To initiate synthesis the helicase binds to the front basic patch(Fbp) of the polymerase
to aid in loading it onto DNA. In the event that pol dissociates from DNA The acidic C-
terminal tail of the helicase is important for keeping the dissociated polymerase tethered to
the moving replisome. In the current model, the helicase C-terminal tail will bind to the
thioredoxin binding domain basic patch (TBDbp) when the pol dissociates from the DNA
and the pol will be rotated so the helicase tail can interact with the FBP to reload onto DNA.
Figure 3 demonstrates how the helicase interacts with both the TBDbp and the FBP.2,14
Figure 3. The helicase must interact with the polymerase during DNA synthesis. The FBP
and the TBDbp are important for keeping the polymerase tethered to a moving replisome.
In the current model to begin replication the C-terminal tail of the helicase will bind to the
Fbp of the pol and load it onto the DNA as seen in figure A and B. In the event that the
polymerase dissociates from DNA the C-terminal tail of the helicase will bind to the TBDbp
and rotate the polymerase to bind to the Fbp to load the polymerase back onto DNA.2
Figure 4 illustrates the location of the TBD and the Fbp on the polymerase.2 This electro-
static interaction is essential for increasing the processivity of the replisome.2 The T7 genome
consists of approximately 40kb which needs to be replicated for phage survival. When the
pol/trx is able to interact with the helicase the replisome has a processivity of 17kb. If the
acidic C-terminal tail of the helicase is deleted, the processivity of strand displacement syn-
thesis decreases from 17kb to 5kb, indicating that the electrostatic interaction is needed for
high processivity between the helicase and the polymerase.1,2 Strand displacement synthesis
5
is the ability of an enzyme to displace DNA encountered essentially unwinding dsDNA and
synthesizing a new strand.
Figure 4. Illustration representing the polymerase/thioredoxin complex structure showing
the locations of the front basic patch and the thioredoxin basic patch2.
1.3 CRYSTAL STRUCTURE
Recently, a three-dimensional structure of the C-terminal tail of T7 primase-helicase bound
to the polymerase was determined by Dr. Wallen using X-ray crystallography (Figure 5).
The crystal structure shows that the C-terminal tail binds in a pocket near Fbp, and the
very C-terminal phenylalanine, which has been shown to be essential for the interaction, is
buried in the hydrophobic cleft of the polymerase (Figure 5). The C-terminal tail of the
helicase is essential. If it is deleted, neutralized, or the C-terminal phenylalanine is mutated,
replication no longer occurs.2,15,16 As seen in Figure 6, the C-terminal tail binds the Fbp
such that the aromatic phenylalanine lies in the hydrophobic pocket, and the tail is further
anchored by two salt bridges involving the D565 side chain and F566 carboxylate of the
helicase with R687 and R590 of the polymerase, respectively. K587, K589, R590, and R591
(Figure 4B) are among the basic residues that have been previously neutralized in the Fbp
and are known to be vital for the interaction between the primase-helicase acidic C-terminal
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tail and the polymerase.2 R590 is the amino acid seen anchoring the helicase tail to the front
basic patch in the crystal structure. We hypothesize that if we mutate R590 the interaction
between the helicase and the polymerase will weaken and T7 will not be able to replicate its
DNA efficiently.
Figure 5. Crystal structure showing T7 helicase peptide (yellow circle in right hand panel)
bound to the polymerases hydrophobic pocket. The panel on the left is color coded based
on charge, blue represent basic amino acids while white represents neutral amino acids.
Figure 6. Close up of the crystal structure illustrating the salt bridges being formed between
the peptide and the polymerase in the front basic patch.
The C-terminal phenylalanine of the helicase fits perfectly into the polymerase hydropho-
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bic pocket, like a lock and key. The amino acids that make up the hydrophobic pocket are
F487, I569, L163, I593, T572. Mutating any one of the amino acids that make up the hy-
drophobic pocket to an alanine we hypothesize will change the shape decreasing or diminish-
ing this hydrophobic interaction. For this study we have preformed site directed mutagenesis
on the following amino acids L613, I569, and F487, mutating each separately to an alanine.
Figure 7 shows the surface representation of the peptide binding in the hydrophobic pocket.
Figure 7. View of the amino acids surrounding the helicase tail peptide. The amino acids
shown in purple are the amino acids that have been mutated to an alanine for this project.
The amino acids shown in white have yet to be mutated.
1.3.1 EXONUCLEASE
Replicative DNA polymerases, such as T7 DNA polymerase, are highly accurate motors.
They require a correct nucleotide to be added to the primer template in order to move for-
ward. For every 103-105 nucleotides incorporated, ∼1 mistake will occur.1 If a mistake does
occur the T7 DNA polymerase contains a exonuclease site that will remove the incorrect
nucleotide. Having the ability to proof-read increases pols fidelity by ∼100 fold. The ex-
onuclease can remove the incorrect nucleotide on ssDNA in the 3’→ 5’ direction. When a
mistake is made the primer template needs to be shuttled over 30Å to the exonuclease site
where it will be removed. Until recently there has been difficulty crystallizing DNA in the
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exonuclease site for the T7 DNA polymerase.1
In the same crystal structure with peptide bound (described above), a nucleotide (dTTP)
is seen in the exonuclease site. In a second crystal structure of polymerase 5A7A bound to
helicase in the presence of dT15 ssDNA, ssDNA was also found in the exonuclease active
site. There has never before been a crystal structure of the T7 polymerase showing ssDNA
or a nucleotide in the exonuclease site. It is not known how the DNA is shuttled to the
exonuclease site to remove the mistake for T7 DNA pol. The crystal structures in Figure 8
reveals the W160 aromatic side chain stacking against a nucleotide in each crystal structure.
Figure 8. Two crystal structures showing the electron density of a nucleotide interacting with
W160 in the exonuclease site. Panel A on the left shows a crystal structure with ssDNA in
the exo site and panel B shows a single nucleotide (dTTP) in the exo site. The base of the
nucleotide is seen stacking with the aromatic side chain of W160.
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In the exonuclease site a sequence alignment seen in Figure 9 shows that residues D5
and E7 are conserved in all 63 T7-like polymerases (30% or greater identity). These residues
coordinate Mg+2 that facilitates the exonuclease attack on DNA. Along with D5 and 7E
W160 is an aromatic residue in all sequences, as either a W or an F. With the sequence
alignment and the crystal structure we hypothesize that this W160 is an essential amino
acid for stabilizing the DNA in the exonuclease site.
Figure 9. Above is a logo graph showing the alignment of T7 Pol with 63 T7-like polymerases
at 30% or greater identity. Residues 5 and 7 coordinate Mg+2 and are absolutely conserved
in all Pols. W160 is an aromatic in all sequences, either as a W or an F.
If W160 is an essential amino acid in the exonuclease site then mutation of this residue
should alter exonuclease activity. W160 has previously been mutated to an A in our lab
(unpublished). To determine if the W160A pol could replicate a normal primer template and
a mismatch primer template like WT, a sequencing gel was ran(Figure 10). The W160A pol
when loaded onto a primer template containing no mutation is able to replicate the template
similar to WT pol. Unlike WT the W160A was not able to replicate the mismatch primer
template. WT pol must remove the mutation before replication can begin. This preliminary
data suggests that the W160 is an essential amino acid for a functioning exonuclease.
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Figure 10. Sequencing gel of W160A and WT pol. This assay compares the w160A ability
to extend DNA on both a normal DNA primer template and a mismatch primer template.
WT pol can extend DNA on both the normal and mismatch primer template. The W160A
can extend DNA on normal DNA primer template but can not complete DNA synthesis on
primer template containing the mismatch. This demonstrates the importance of the residue
W160 for the exonuclease activity of the T7 DNA polymerase. If the polymerase can not
correct a mistake in this case a mismatch then the T7 DNA pol can not continue synthesizing
DNA. (Data obtained previously by Dr. Wallen)
This thesis will focus on 1) validating the electrostatic interaction between the C-terminal
tail of the helicase and the Fbp of the pol. Understanding at the molecular level how this
interaction coordinates the replisome and 2) Verify that W160 is an essential amino acid in
stabilizing the DNA in the exonuclease site.
1.4 SSB AND PATHOGENIC BACTERIA
The SSB C-terminal tail is very similar to that of the primase-helicase. Both tails have many
acidic residues essential for interacting with the polymerase, as seen in Figure 11. The last
two amino acids are identical which includes the imperative C-terminal phenylalanine and
many acidic residues are conserved. The acidic residues of the tail along with the C-terminal
phenylalanine are essential for DNA replication.17–19 With the similarities between the SSB
and helicase C-terminal tail we hypothesize that the SSB tail will bind to the same site of
the polymerase Fbp as seen with the helicase peptide in the crystal structure.
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Figure 11. Sequence alignment of the helicase C-terminal tail and the SSB C-terminal tail.
Notice that both the helicase and the SSB contain the end terminal phenylalanine (denoted
by the letter F) and many acidic residues highlighted in red.
It is known that the C-terminal region of the SSB is essential for DNA replication.1,20,21
The binding of the SSB to polymerase is the same within pathogenic bacteria but not in
eukaryotes, making this a perfect interaction to study for drug development.1 The SSBs from
many bacteria are structurally similar to that of T7 and are expected to bind to polymerase
in a similar fashion. To illustrate, Figure 12 provides amino acid sequences for the C-
terminal tail of T7 SSB protein and several pathogenic bacteria. Note that the C-terminal
sequence for all the SSBs in Figure 12 end with the same amino acid, phenylalanine (given
the letter F) and that there are many other conserved acidic amino acids in their sequences.
Also note that the bacteria in Figure 12 are pathogenic and cause the following diseases:
Staphylococcus (Staph), Streptococcus (Strep), Salmonellosis (Salmonella), and Bordetella
Pertussis (Whooping cough), which are all becoming dangerously resistant to antibiotics.
Thus, understanding how SSB binds polymerase in our T7 model system may lead to new
drugs that will prevent this protein/protein interaction and kill these pathogenic bacteria.
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Figure 12. Bioinformatics comparison of T7 SSB tail to bacterial SSBs; staph, strep, bor-
detella, and salmonella. The end terminal phenylalanine (given the letter F) is conserved in
all SSB and is known to interact with the DNA polymerase. The amino acids (D and E) are
present in all sequences indicating that all these SSB likely interact with polymerase in the
same way as T7 SSB.
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CHAPTER 2 INTRODUCTION TO RESEARCH
2.1 OBJECTIVES
This thesis will focus on validating the interactions seen in these three dimensional structures
to understand how the electrostatic interaction coordinates the replisome at the molecular
level. Additionally, we will verify that the W160 is an essential amino acid in stabilizing the
DNA in the exonuclease site.
Several experiments have been performed to validate the crystal structure showing the
electrostatic interaction between the C-terminal tail of the helicase and the Fbp of the poly-
merase along with the W160 as an important residue of the exonuclease site. Site directed
mutagenesis was carried out on several of the amino acids in the Fbp of the polymerase
including L613, F487, R590, R687, and I569. W160 was also mutated to an A to test the
importance of the aromatic nature. The effect of these mutations was studied using phage
complementation, rolling circle, multi-step growth curve, and primer extension assay.
2.2 PHAGE COMPLEMENTATION
Phage complementation was used to determine how point mutations of the Fbp affect repli-
cation of the T7 phage in vivo. A T7 phage that is missing the polymerase gene is used in
these experiments (∆gp5). Without the gene for the polymerase the phage cannot replicate
and therefore cannot infect its host E. coli. By providing the polymerase gene via a separate
DNA plasmid the ability for the phage to replicate is restored and results in an infectious
phage as seen in Figure 13.
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Mutations of the polymerase gene can easily be made on the plasmid DNA and the effects
of these mutations can be studied to determine which specific amino acids are vital for phage
growth and survival. If an amino acid that is essential for replication is mutated it can lead
to no phage growth, no plaques visible, or a change in plaque phenotype.
Figure 13. Phage complementation is a technique used to quantify the effects that the point
mutations have on the growth of T7 phage in vivo. From left to right Figure A demonstrates
wild type plaque formation. The wild type phage contains all genes necessary for the phage
survival in E. coli producing plaques in the bacterial lawn. Figure B contains a T7 phage
with the deleted polymerase gene that is needed for the phage to grow. Without this gene
the phage can no longer survive and plaques will not form. Figure C demonstrates how
the phage complementation technique is performed. The T7 phage has the polymerase gene
deleted(∆gp5) from its genome. A DNA plasmid is transformed into the E. coli cells con-
taining the polymerase gene. By adding the polymerase gene to the plasmid it complements
the the ∆gp5 phage and allows for plaques to once again form. Mutations can easily be
made on the plasmid and the effects of phage survival can be quantified.
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2.2.1 GROWTH CURVE
A multi-step growth curve is used to study the effects the point mutations have on the phage
growth over time. E. coli cells are infected with a multiplicity of infection (MOI) of 1x10−7
to 1x10−9 of phage. The infected cells are grown at 37◦C and samples were taken at 2,4,6
and 15 hours. The samples are spotted onto the bacterial lawn and the plaques are counted
to determine a titer of virus. This assay will allow us to compare the mutation’s effects
on viral growth. If the replisome cannot coordinate due to our mutations, then replication
cannot occur and the phage cannot survive. The mutation is detrimental, such that pol and
helicase cannot interact, then no viral growth will occur. If the interaction is weakened, then
that will become evident by a delayed viral growth over time.
2.3 ROLLING CIRCLE
The rolling circle replication assay is used to test the ability of the polymerase to synthesize
DNA and the replisomes ability to coordinate and synthesize DNA. Rolling circle uses a
single stranded circular piece of DNA from the virus M13. A primer complimentary to
the M13 DNA is bound to a FAM label and is annealed to the ssDNA for polymerase and
helicase to load. A dT35 tail is added to the 5’ end of the primer. This does not anneal with
the M13 DNA and provides a fork-shaped structure that is required for primase-helicase
loading. Figure 14 describes how rolling circle is carried out. To test if the mutations alter
the ability of the polymerase to synthesize DNA only the pol/trx complex is loaded onto the
ssM13. If the pol can synthesize DNA it will be able to complete the circle until it reaches
the tail. Without helicase pol/trx cannot perform strand displacement DNA synthesis.1,2
Once helicase is added strand displacement DNA synthesis can occur and the pol/trx can
continuously synthesize DNA around the circle. Under these conditions we are only able
to monitor the ability of primase-helicase and polymerase to carry out coordinated leading
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strand synthesis.1,22
Figure 14. The rolling circle assay tests the replisomes ability to synthesize DNA. A) The
ssM13 DNA is annealed to the FAM labeled primer. Without the helicase the wild type
polymerase will be able to synthesize the circle piece of DNA until it encounters dsDNA.
Without the helicase the wild type polymerase can not perform strand displacement synthesis
and will stop once it synthesizes around the M13 once. B) When helicase is added to the
reaction the polymerase and helicase can continually synthesis the circular DNA. Without
the small RNA primers the complex cannot synthesize lagging strand and only the leading
strand will extend.[gp5=polymerase; gp4=Helicase]
By adding the helicase we can determine if the mutated amino acids of the Fbp are vital
for the electrostatic interaction between the helicase and the polymerase. Previously the
entire Fbp was neutralized and it was shown that this interaction can no longer occur and the
polymerase can not synthesize DNA on a dsM13 template.2 We hypothesize that mutating
any one of the amino acids that displayed a phenotype in the phage complementation assay
they will have diminished electrostatic interaction and pol will only be able to replicate the
ssM13 to the double stranded product.
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2.4 SAXS
Small angle X-ray scattering (SAXS) is a method used to characterize the structure and
shape of molecules in solution. It is also used to calculate the molecular weight and the
concentration of homogeneous molecules in solution making it possible to determine a mo-
lar ratio.23 The T7 replisome consisting of T7 polymerase, Trx, and primase-helicase was
crystallized and the X-ray structure was determined by Dr. Wallen previously. This crystal
structure shows three polymerases bound to a hexameric helicase, pol A, B, and C (Figure
15).
Figure 15. Crystal structure showing three polymerases bound (A, B, and C) to hexameric
pirmase-helicase. Polymerase A and B are bound to the helicase in the same orientation while
polymerase C is rotated 90◦ and leaning toward the outside of the helicase ring. Polymerase
A and B are hypothesized to be the polymerases that are used to replicate both strands of
DNA while pol C is bond to helicase in the event that either of the other pols dissociate
from the complex.
In this crystal structure polymerases A and B are bound to helicase in the same orien-
tation. Polymerase C is rotated about 90◦ and is leaning toward the outside of the helicase
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ring. Only two copies of polymerase are needed to synthesize the leading and lagging strands
DNA. This structure shows that polymerase A and polymerase B are positioned to replicate
both strands while polymerase C might be bound in case pol B or C are dissociated. SAXS
was performed on this complex to observe the structure in solution. The SAXS data was
analyzed using FoXS.24 This data was used to confirm that in solution this complex is the
same as the crystal structure.
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CHAPTER 3 EXPERIMENTAL
3.1 CLONING
All DNA samples were sequenced in-house using the Big Dye Terminator Cycle Sequencing
Kit v.1.1 on the ABI 3730xl Sequencer (Applied Biosystem, USA) using 80cm capillary tubes
for plasmid DNA or from Genewiz using T7, T7 term, and GP1-forward primers.
Mutations were introduced into the T7 gene 5 (polymerase) located in a pET21b plasmid
by site directed mutagenesis.25 Primers were obtained from Integrated DNA Technologies
(IDT). The plasmid was then transformed into DH5α E. coli cells to amplify the mutated
DNA produced. To confirm that DNA was made during the site directed mutagenesis the
samples were ran on a 0.8% agarose gel. The samples containing DNA were then purified
using a standard miniprep kit from Qiagen and the plasmid DNA was sequenced to confirm
the correct mutation.
3.2 PROTEIN PURIFICATION
All columns for protein purification were purchased from either Biorad or GE Healthcare.
gp 2.5 Single Stranded Binding Protein : The pET21b vector that was used con-
tains the full length SSB containing a precision protease site for the N-terminal His tag. This
vector was transformed into BL21 (DE3) cells for overexpression of SSB. SSB was purified as
previously described.19 The SSB was first loaded onto a nickel affinity column. Equilibrated
with buffer A: 50mM Tris pH 8, 200mM NaCl, 10mM imidazole, 10% glycerol, and 1mM
BME. Buffer B containing 250mM imidazole was used to elute the protein with a gradient
of 0-100% over 100mL. PreScission Protease was added to the purified protein at a ratio
of 1:100 and the mixture was dialyzed overnight at 4 ◦C against 20mM Tris-HCL pH 7.5,
20
200mM NaCl, 0.1mM EDTA, 1mM DTT, and 5% glycerol. The protease was then removed
by running the SSB over the Hi-Trap Nickel column again. The protein was further purified
with a Hi-trap Q column followed by a Sephacryl HR 26/60 gel filtration column. Buffer A
for the Q column contained 20mM Tris pH 7.5, 1mM EDTA, 1mM DTT and 5% glycerol.
Buffer B for Q column is the same as A but contains 1M NaCl. Buffer B was used to elute
the protein from Q column at a gradient of 0-100% B over 100mL. Buffer A for column Q was
also used for the gel filtration column. The protein was identified using a 12% SDS-PAGE
gel and pooled together and concentrator down using a concentrator. The extinction coef-
ficient to determine concentration is 1.28g/L or 32890 M−1 Cm−1. 1.7 mg/mL, or 20µM,
was purified from 6 liters of E. coli.
gp5 Polymerase/Thioredoxin : The gp5 polymerase and Trx are expressed and har-
vested separately and mixed together in order to purify the gp5/Trx complex. HMS174(DE3)
cells are used to co express both polymerase and RSF-Trx to limit proteolysis. Expression
of Trx is low and therefore the Trx is separately expressed using the pTRX plasmid. To
co-express polymerase in a pET21b plasmid and RSF-Trx, 6L of HMS174 (DE3) cells were
grown at 37◦C to 0.6-0.8 OD600 and the cells were induced with 1mM IPTG for 3 hours
at 37◦C. The cells were then harvested by spinning at 3500 RPM for 20 minutes and the
bacterial pellet was re-suspended in 120mL of 25mM KPO4 pH 8.0, 600mM KCl, and 10%
glycerol. This solution was then stored at -80◦C.
Thioredoxin is over expressed in HMS174 (DE3) cells using the plasmid pTRX. 6L of
cells were grown at 37◦C for approximately 6 hours to 1.5 OD600 and then induced with
0.5mM IPTG and left to grow overnight at 37◦C. The cells were harvested by spinning at
3500RPM for 20 minutes and the pellets were washed with 50mM Tris-HCl pH 7.5, 20mM
EDTA, and 10% glycerol. Cells were then spun at 3500RPM for 20 minutes and the bacterial
pellets were resuspended in 80mL of 50mM Tris-HCl pH 7.5, 1mM EDTA, and 10% glycerol
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and stored at -80◦C.
Once both proteins were available, both the Trx cells and pol/Trx cells were thawed and
mixed together. Not only does the polymerase become more active by mixing thioredoxin
with the polymerase but there is also a lesser chance of proteolysis. PMSF (0.2mg/mL)
was added to the suspension and the mixture was left to stir at 4◦C for 30 minutes. The
cells were then lysed by sonication and spun down at 17000 RPM for 50 minutes to pellet
the cell debris. The supernatant was collected and the nucleic acids were precipitated by
slowly adding 0.5% final concentration of polyethyleneimine (PEI) with stirring at 4◦C for
20 minutes. The suspension was spun at 17000 RPM for 40 minutes to pellet the DNA. The
supernatant was collected and 60% saturation of ammonium sulfate was added to salt out
the protein. It was stirred for 60 minutes and spun down at 17000 RPM for 20 minutes. The
supernatant was then removed and the protein pellet was resuspended in 100mLs of 20mM
Tris-HCl pH 7.5, 1mM EDTA, 1mM DTT, and 5% glycerol.
The resuspension was loaded on an ion exchange column, (HiTrap Heparin) HP column,
that was equilibrated with Buffer A (20mM Tris-HCl pH 7.5, 1mM EDTA, 1mM DTT,
and 5% glycerol). The protein column was washed with 30mL of buffer A and the protein
was eluted over a gradient of 0−100% Buffer B(1M NaCl, 20mM Tris-HCl pH 7.5, 0.1mM
EDTA, 1mM DTT, 5% glycerol) while collecting 3mL fractions. Identification of protein
was done with SDS-PAGE and the polymerase fractions were pooled together. The protein
was diluted to a 100mM salt concentration with buffer A and loaded onto Hi-Trap Q HP
column preequilibrated with Buffer A. Protein was eluted with a gradient of 0−80% NaCl.
The protein was collected in 3mL fractions and identified using SDS-PAGE. The fractions
were pooled and dialyzed for 3 hours in dialysis buffer (10mM KPO4 pH 7.4, 5% glycerol and
1mM BME). The dialyzed protein was then loaded onto Mini CHT Ceramic Hydroxyapatite
preequilibrated with Buffer A (10mM KPO4, 5% glycerol, and 1mM BME). The column was
then washed with 30mL of 100% A and the protein was eluted with a gradient of 10−500mM
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KPO4 collecting 1mL fractions. The protein was identified by SDS-PAGE and the fractions
were pooled together and concentrated down to 1mL to be injected into a GE Sephacryl HR
26/60 gel filtration column. The protein was eluted with 20mM Tris-HCl pH 7.5, 100mM
NaCl, 0.5mM EDTA, 1mM DTT, 5% glycerol. Pol/Trx complex is about 92KDa and gel
filtration shows that the protein elutes as a monomer. The fractions are pooled and identified
using a 15% SDS-PAGE gel. The sample was concentrated down using a concentrator. The
extinction coefficient to determine concentration is 1.644g/L or 150230M−1 cm−1. 3.5mg/mL
or 13µM, was purified from 6 liters of E. coli. The protein was aliquoted and flash frozen in
liquid nitrogen to be stored at -80◦C.
The R590A mutant was successful expressed and purified as described for WT pol. The
R590A was concentrated down to 11µM or 0.5mg/mL.
3.3 HARVESTING T7 PHAGE
To study the effects of the mutations of the T7 DNA polymerase we need to grow and harvest
∆gp5 phage.26,27 0.05-0.2mL of ∆gp5 phage were mixed with 0.25mL BL21 E. coli and 2.5
mL top T-broth agar(0.1% tryptone, 0.005% NaCL, and 0.7% agar). This mixture was
poured evenly on the T-broth bottom agar (1% agar). The plates were incubated overnight
at room temperature or at 37◦C for 2-3 hours. A single plaque was picked and added to
5mL fresh overnight E. coli culture and 15mL T-broth in a 125mL Erlenmeyer flask. The
culture was shaken at 30◦C for 2-4 hours or until lysis occurs. 1g of NaCl is added to the
culture and then spun at 10,000 RPM for 10 minutes. The supernatant was collected in a
sterile tube and filtered using a 0.22µm bottle top syringe. The virus was stored at 4◦C.
From 15mL T-broth we obtained a viral titer of 7.89 PFU/mL.
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3.4 PHAGE COMPLEMENTATION
Phage complementation was used to determine the effect the specific mutations have on
viral replication in vivo.28 BL21 E. coil cells with either the WT or mutant gp5 were grown
overnight in 5mL of lysogeny broth (LB). Ampicillin is included in broth and agar to insure
plasmid remains in the cells. The next morning 100µL of the overnight culture was added
to 3mL of LB and allowed to grow to an OD600 of ∼1 at 37 ◦C. 300µL of the culture was
placed into a 1.5mL eppendorf tube and mixed with 200µL ∆gp5 T7 virus at a concentration
of 1x10−8PFU/mL. Top agar(0.7% LB agar) was melted and kept at 55 ◦C and 1mL with
100µ mL ampicillin was added to the bacteria viral solution. The solution was mixed by
pipetting up and down several times and then plated onto 1% LB bottom agar using three
well plate. The plates were incubated for 4 hours at 37 ◦C and the viral plaques were counted
to determine a titer or plaque forming units per milliliter by the equation
PFU
mL
=
n
V D
(3.4.1)
where n is defined as the number of plaques counted, V is amount of viral sample plated,
and D is the dilution factor of the virus.
3.4.1 SPOT TEST
Spot tests were also performed to determine the viral titer range to add to the plaque assays.
This was done by plating the bacteria (grown to an OD 0.6-0.8) and LB top agar on to LB
bottom agar plates. The top agar was left to harden and dry under a sterile hood for 5
minutes and the virus was serially diluted 10-fold for a range of 11x10−2 to 1x10−8, then
2µL was spotted onto the bacterial lawn. If the mutated phage is able to grow in vivo
plaques will form where the virus was spotted. Viral plaques appear to be small holes in the
bacterial lawn.
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3.4.2 GROWTH CURVE
The growth curve assay determined the effect the mutations had on the growth rate of the
phage. BL21 E. coli cells, with the pET21 plasmid containing polymerase, were inoculated
in 5mL LB with 100µg/mL ampicillin and let to grow overnight at 37◦C. 1mL cultures
containing 100µg/mL of ampicillin were inoculated with 100µL of overnight culture are grown
to OD 0.6-0.8. They were infected with ∆gp5 T7 phage at an MOI of 1E−9. 50µL samples
were taken at time 0 and every 2 hours for 6 hours and one sample was taken overnight
at 15 hours. These samples were spun down to remove all cells and the supernatant was
collected and stored in the fridge. Once all samples were collected each supernatant sample
was serially diluted 10 fold 7 times.
Wild type E. coli cultures were grown to an OD 0.6-0.8 at 37◦C. The E. coli cells were
mixed with top agar heated to 50◦C, at 200µL cells/mL top agar. The top LB agar mixture
was plated on top of LB bottom agar also containing ampicillin. Once the top agar solidified
5µL of collected samples were spotted on the top agar for each time point and each dilution.
The plates were let to incubate at 37◦C for 4 hours. At 4 hours the individual plaques were
counted for the lowest dilution of viral growth to obtain a viral titer. Wild type polymerase
was compared to four mutations (R590A, F487A, I569A, and R687A).
3.5 ROLLING CIRCLE
To study the polymerases ability to interact with the helicase and synthesize DNA rolling
circle replication assay can be used. We can look at the effects the single mutations of the
Fbp and the exonuclease site have on the pol ability to synthesize DNA.
Sample (45µL) samples containing 500nM dNTP’s,20nM primed ssM13, and 20nM poly-
merase were prepared in 25mM tris-HCl pH 7.5, 100mM NaCl, 5mM MgCl2, and 5mM
DTT buffer. Samples before adding enzyme were preheated at 37◦C in a water bath. The
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reactions were started by the addition of enzyme, and all assays were performed at 37◦C.
Samples were quenched at 10s, 30s and 2min with 50mM EDTA, 0.2% SDS and 10% glyc-
erol. Samples were incubated at 37◦C until quenched. The samples were loaded onto 0.6%
agrose gel containing ethidium bromide dye (EtBr) and ran at 150V for 1.5 hours. The gel
was imaged using a Biorad ChemiDoc MP imager.
Table 1. M13 primer used for this study
DNA Oligos Oligo Sequence
M13 rollingprimerFAM 5’FAM-(dT35)GTGTAAAACGACGGCCAGTGC
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CHAPTER 4 RESULTS AND DISCUSSION
4.1 PURIFICATION
T7 DNA polymerase had been purified previously using phosphocellulose as the first col-
umn.29 This column is no longer available on the market, and therefore part of this thesis
was focused on developing a new method of purification. Heparin was found to be a suit-
able replacement for Phosphocellulose, as the polymerase bound and eluted well from the
column. The columns are in order HiTrap Heparin HP, Hi-Trap Q, hydroxyapatite, and
sepharyl HR 26/60 gel filtration. WT DNA polymerase and R590A were successfully puri-
fied using this method. WT polymerase was purified at 3.5mg/mL while R590A was purified
at 1.19mg/mL.
WT polymerase was first purified using Heprin, a cation exchange column. Figure 16
shows the chromatogram and the SDS gel of the fractions for the first column.
Figure 16. The chromatogram on the left after the Heprin column. Fractions 1-12 are flow
through represented on the gel in lanes 2-7. Lanes 8-13 contain every other fractions from
26-36 which contain WT pol. Fractions 27-33 were pooled to eliminate impurities. These
fractions were diluted to 10% salt and loaded onto Hi-Trap Q column.
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After running WT pol over the Heparin column fractions 27-33 were pooled together and
diluted to 10% salt. The pol was then loaded onto a Hi-Trap Q ion exchange column. Figure
17 shows the chromatogram and SDS gel of the fractions for the Q column.
Figure 17. The chromatogram on the left is after running the pol over the Q column.
Fractions 10-12 contain a bubble. Pol and Trx co-purify and Trx is marked by a blue box in
the SDS gel. Fractions 20-33 contain the WT pol/Trx. Every other fraction was collected
from 23-31 and are on lanes 3-7 on the SDS gel. These lanes contain WT pol/Trx. All
fractions 23-31 were pooled and put on dialysis buffer for 3 hours before being loaded onto
the hydroxyapatite column.
Fractions 23-31 were pooled after the Hi-trap Q column. These fractions containing the
protein were put on dialysis buffer for 3 hours before being loaded onto the Hydroxyapatite
column. Figure 18 shows the SDS gel and chromatogram for the Hydroxyapatite column.
The Hydroxyapatite column is used to purify the polymerase fully bound to Trx to insure
that the polymerase is active. This column is an ion exchange column and mimics the DNA
backbone, making it an ideal column to purify the active T7 DNA pol/Trx complex.
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Figure 18. The left panel shows the chromatogram for pol/Trx complex after being eluted
off of the Hydroxyapatite column. The Hydroxyapatite column is an ion exchange column
and mimics the DNA backbone. This column is used to purify the most active polymerase
bound to Trx. The chromatogram shows 5 peaks, the first two are from being overloaded as
seen with littler separation of the two peaks. Peaks 3 and four contain are well separated
and contain pol/Trx. The third peak contains the most active pol/Trx complex while the
fourth peak is less active. The right panel is of the SDS gel for the eluted sample. Lanes 2-5
contain fractions from the first and second peak. Lanes 7-12 contain every other fractions 19-
30 and lanes 13-14 contain fraction 39 and 45. The SDS gel shows that peak 3 contains both
polymerase and high concentration of Trx indicating this is the most active polymerase.
Fractions 19-30 were pooled and concentrated down to 1mL and loaded onto the sizing
column.
Once the protein was eluted fractions containing the active pol/Trx (fraction 19-30) were
pooled and concentrated down to 1mL. The concentrated protein was loaded onto the sizing
column. Figure 19 shows the chromatogram and SDS gel of eluted protein.
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Figure 19. Chromatogram on the left shows the pol/Trx started to elute at 100 minutes
from fractions 5-17. The SDS gel on the right compares pure WT pol/Trx in lane 3 to
the fractions sampled (5-17). T7 DNA Polymerase has a molecular mass of ∼ 80Kda and
it binds to Trx with a mass of ∼ 12kda.1 According to the SDS gel we have successfully
purified pol/Trx complex.
Fractions 5-17 were pooled and concentrated down after elution from sizing column. The
protein was sucessfully purified usin this new method. The protein was concentrated to
3.5mg/mL for WT and 1.7mg/mL for R590A.
4.2 PHAGE COMPLEMENTATION
The ∆gp5 phage was complemented with a plasmid transformed into BL21 E. coli cells.
Phage complementation tests how well the phage can survive in vivo when mutations are
introduced into the essential DNA polymerase. Amino acids of the Fbp, hydrophobic pocket,
and exonuclease of the polymerase were mutated and tested using phage complementation.
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4.2.1 FRONT BASIC PATCH
To determine the appropriate concentration of virus for a plaque assay, a spot test was
performed. The mutations of the Fbp and hydrophobic pocket are compared in Figure 20.
WT polymerase is seen to form plaques at 1x10−8 dilution while the mutations F487A,
R687A, and I569A form plaques only to 1x10−5 dilution. R590A being the weakest of all
the mutations only forms plaques to the 1x10−4 dilution.
Figure 20. The spot test performed showed wild type pol forming plaques at 1x10−8 while
F487A, R687A, and I569A could only form plaques at 1x10−5 dilution. R590A was even
more of a detrimental mutation only being able to form plaques at 1x10−4 dilution. This
assay demonstrates how the point mutations have impaired the phage survival.
When performing a plaque assay the amount of virus that is added is very important.
If you add a concentrated amount of virus the effects of the mutations may not be seen.
Since WT can form plaques at the lowest dilution (1x10−8) the plaque assays will be plated
at this dilution. Table 2 show the titer calculated for each mutation for the plaque assays
performed. WT gives a titer of 2.8x109 while R590A, F487A, and I569A did not form plaques
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at the same dilution. The results suggest that these amino acids play an essential role in
replication. R687A had a different phenotype than wild type, as it did form plaques but
they were much smaller making them hard to count. The smaller plaques suggest that the
virus is sick as compared to WT, which suggests that R687 does play an important role in
replication.
Table 2. Titer of ∆ gp5 T7 phage plated onto E. coli containing WT pol. The phage was
plated at a 10−8 dilution.
Pol pfu/mL at 10−8 dilution
WT 2.8x109
R590A no plaques observed
F487A no plaques observed
I569A no plaques observed
R687A plaques visible but very few and too small to count
4.2.2 EXONUCLEASE
To understand the role of W160 in exonuclease activity, a spot test was also performed on the
exonuclease mutations (Figure 21). For this assay WT formed plaques to 1x10−7 dilution.
Seen in Figure 21, the behavior of the mutations are identical to WT and form plaques to
1x10−7 dilution. There are several possibilities 1) that error prone synthesis is occurring and
the phage is still able to survive 2) there are other proteins in the host that help repair DNA
damage caused by mistakes made by the T7 DNA polymerase. Figure ?? demonstrates that
5A7A and W160A are unable to fix mistakes on small primer/template substrates.
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Figure 21. The exonuclease mutations were not seen to be detrimental to the phage and
both W160A and 5A7A were able to form plaques at the same dilution as WT, 1x10−7.
The countable spots at the lowest dilution were determined for each polymerase. Table
3 is the calculated titer for WT, W160A, and 5A7A. The titers found for the mutations are
similar to WT.
Table 3. Titer of WT, 5A7A, and W160A from spot test. All three were seen to form plaques
at 1x10−7 dilution
Pol pfu/mL
WT 2.4x1012
W160A 1.8x1012
5A7A 2.6x1012
4.3 GROWTH CURVE
To study the effects of the mutation on growth of the phage over time, a multi-step growth
curve was performed. BL21 E. coli cells were infected with a 1x10−7 MOI of phage. These
cells were grown for 15 hours and samples were taken every two hours for 6 hours and 1
sample at 15 hours. At this MOI, WT pol was seen to plateau at 4 hours at a titer of
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1.4x107 PFU/mL while R590A did not show any growth (Figure 22). These results show
that at an MOI that supports WT phage growth, R590A is unable to replicate the phage
DNA.
Figure 22. Growth curve of WT and R590A at an MOI of 1x10−7. These samples were
grown for15 hours. R590A shows no growth for 15 hours while WT grows to a titer of
1.4x107 PFU/mL before leveling off. R590 is a vital amino acid and when mutated to an
alanine can no longer grow in vivo.
Preliminary data for the F487A and I569A mutants are seen in Figure 23. To see the
effects of these mutations the MOI was much lower than that of R590A. Samples were grown
for 15 hours and samples were taken every hour for 5 hours and one sample at 15 hours. As
observed perviously, WT phage grows and plateaus at 4 hours at a titer of 1.4x107 PFU/mL
at an MOI of 1x10−9 WT plateaus at 5 hours at titer of 6x1012. At this MOI the WT
phage can reach a higher concentration of virus before plateauing. The mutants F487A and
I569A both plateau at 4 hours with a titer of 3.6x1010 PFU/mL and 1.2x1010 PFU/mL
respectively. This data was not completed in triplicate and needs to be continued in future
work. Although, these mutants are not as detrimental as R590A, they still impact the phages
ability to replicate. This data suggests that the electrostatic interactions (R590) with F566
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appears to be more important than the hydrophobic pocket itself. This however is limiting,
as we need to perform more experiments.
Figure 23. Preliminary data shows the mutants are impaired, in their growth over time
compared to wild type, at an MOI of 1x10−9.
4.4 ROLLING CIRCLE
We recently optimized the rolling circle assay. Several kinds of gels were attempted to
obtain sharp and visible bands. We were able to optimize an acrylamide gel with EtBr for
this assay. The ssM13 circular DNA is annealed to the M13 rollingprimerFAM (Table 1).
Since the primer has a FAM label we wanted to image the gel without any dye but the
imager at Western Carolina University is not sensitive enough to read 50nM FAM labeled
DNA. Rolling circle demonstrates the ability of the pol to synthesize DNA and is able to
test all the mutants created. The ssM13 DNA is 7,249bp in length and is single stranded.
If the polymerase can synthesize DNA we hypothesize that it will synthesize the double
stranded M13 product one time. We hypothesized that the mutations of the Fbp would not
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effect the ability of the polymerase to synthesize DNA since it is not related to the active
site. However, due to results from previous experiments of the exonuclease mutants 5A7A
and W160A, we hypothesized that the polymerase would not be able to complete the ssM13
primer template. Since this site allows the polymerase to fix mistakes made if it is no longer
active previous data has shown that the polymerase will lock onto a linear primer template
and can no longer continue synthesis (Figure10). Future work will use this assay to look at
the electrostatic interaction between the pol and C-terminal tail of the helicase. As of now
we are only able to test if the mutants are able to synthesize DNA.
For this assay WT, 5A7A, R590A/5A7A, and W160A were used. Figure 24 shows the
acrylamide gel for each reaction. The reactions were quenched at 10s, 30s, 2min, and 60min.
All polymerases are able to synthesize the dsM13 product at ∼2min. At 60min WT poly-
merase and W160A have completed the dsM13 product as hypothesized. What is interesting
is 5A7A and R590A/5A7A seem to have the ability to perform strand displacement which
disagrees with our hypothesis. If the polymerase loses its exonuclease activity then the
polymerase is able to unwind dsDNA and continue on in the rolling circle.
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Figure 24. Rolling circle results. For each reaction, aliqupts were quenched at 10s (lanes
3 and 7), 30s (lanes 4 and 8), 2min (lanes 5 and 9), and 60min (lanes 6 and 10). A) WT
polymerase and 5A7A mutant. Lane 2 contains M13 DNA only with the FAM labeled
primer. At 2min (lane 5) the WT polymerase has completed synthesizing the M13 DNA and
it is now double stranded. 5A7A continues synthesizing the DNA and is seen to perform
strand displacement synthesis for lane 10 at 60s. The mutation in the exonuclease site allows
the polymerase to continue on. B) Lane 2 contains ssM13 DNA and FAM labeled primer.
R590A/5A7A is also seen to perform strand displacement synthesis lane 6 at 60s. W160 is
similar to WT and it completes the dsM13 product at 2min and is completely finished at
60min.
Future work will be to further test rolling circle by adding helicase or a mismatch to
the primer template. By adding helicase we will be able to see how well the Fbp and
hydrophobic pocket mutants can perform strand displacement. If a mismatch is added to
the primer template we will be able to see how the exonuclease mutants can synthesize DNA
faced with a known mutation that needs to be corrected.
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4.5 SAXS
The SAXS data collected was modeled using the program FoX’S doc. The data for the
structure in solution was hypothesized to be similar to that of the crystal structure (Figure
25). However, the model data of the polymerase B bound to a hexameric helicase is different.
When comparing the data generated from FoX’s doc the best fit when comparing to the
crystal structure is a model of the DNA polymerase lying across the C-terminal face of the
helicase. Compared to the crystal structure this model exposes the Fbp for what seems to
be a way to stabilize the interaction with the C-terminal tail of the helicase. Depending on
what is needed during replication the DNA polymerase is loosely bound to the Fbp so it can
move around.
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Figure 25. The crystal structure (magenta) reveals that the structure in solution differs
from a model based on the interaction of Pol B with gp4 in the crystallized replisome. The
polymerase in the model is leaning in toward the helicase ring. This model displays how the
replisome has different modes of binding and is dynamic depending on what is needed for
replication.
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CHAPTER 5 CONCLUSIONS AND FUTURE WORK
This thesis focuses validating protein/protein interactions observed in a crystal structure.
This crystal structure shows the essential C-terminal tail binding to the polymerase Fbp
and hydrophobic pocket. The T7 replisome is a coordinated system, if one or more proteins
cannot interact then DNA synthesis cannot occur. The aromatic nature of the C-terminal
F566 is essential for DNA synthesis and if it is mutated or removed DNA synthesis cannot
occur. It is important to understand how this tail interacts with the polymerase, as it can
give insight into how more complex replication systems interact. This crystal structure also
shows W160 in the exonuclease site stacking with the base of a nucleotide triphosphate. We
hypothesize that this amino acid is used in stabilizing the DNA in the exonuclease active
site.
To verify the importance of these interactions site directed mutagenesis was performed
on the amino acids involved. In the hydrophobic pocket F487, I569, and L613 were mutated
to an A. Two amino acids in the Fbp (R687, and R590) that form a salt bridge with the
C-terminal tail were also mutated to A. In the exonuclease site the W160 was mutated to an
A to determine if the aromatic nature of the amino acid is essential for stacking with the base
of the nucleotide. Several assays were performed to verify these interactions including: phage
complementation, growth curve assay, rolling circle replication assay, and primer extension
assay. These assays helped to determine which of these amino acids, if not all, are essential
for coordinating the replisome and DNA synthesis.
Phage Complementation : The spot test used for phage complementation demon-
strated how the mutations effected the phage growth in vivo. WT polymerase was able to
form plaques at the highest dilution of 1x10−8 while the mutants F487A, I569A, and R687A
could only form plaques at 1x10−5 dilution. R590A formed plaques at an even lower dilution
of 1x10−4. These mutations have caused a 3 log and 4 log difference in plaque formation
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compared to WT. When plating these mutations and WT at a 1x10−8 PFU/mL a titer was
calculated for each. WT had a titer of 2.8x109 while no plaques were observed for R590A,
F487A, and I569A. Plaques were visible for R687A but the plaque size was much smaller
than WT and a titer could not be calculated. The smaller plaques suggest this mutation has
weakened the growth of the phage showing that R687 is a vital amino acid. From the spot
test and plaque assay we can conclude that these amino acids play an important role phage
growth and survival.
The exonuclease mutants (W160A and 5A7A) were also tested using phage complemen-
tation. These mutations formed plaques at the same dilution (1 x 107), as WT. The titers
were calculated at 2.4x1012, 1.8x1012, and 2.6x1012 for WT, W160A, and 5A7A, respectively.
Since these mutations do not alter the growth of the phage we hypothesize that the poly-
merase can still survive even though mistakes made during replication are not corrected. We
suspect the polymerase with these mutations make mistakes when synthesizing DNA since
the exonuclease site is not active and mutations cannot be corrected. The phage could still
survive if there are other proteins recruited to fix the DNA damage, or if the mutations are
not detrimental to the phage.
Growth Curve : The amino acid R590 proved to be essential for replication in the
multi-step growth curve assay. At an MOI of 1x10−7 WT grew for 4 hours before plateauing
at a concentration of 1.4x107PFU/mL while R590A did not show any growth over the 15
hour time period. These results show that, at an MOI that supports WT growth, R590A
is unable to replicate phage DNA. We conclude that the interaction observed between R590
and the primase-helicase F566 main chain carboxyl is needed for efficient replication of the
phage.
A lower MOI (1x10−9) was required to see the effects of mutations F487A and I569A
have on phage in E. coli. Preliminary data reveals that the WT grows for 5 hours until
reaching the maximum concentration of phage at 6x1012PFU/mL. F487A and I569A grow
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for four hours before plateauing at titers of 3.610PFU/mL and 1.2x1010PFU/mL. This data
was not completed in triplicate and this study will be continued in the future. WHile
these hydrophobic pocket mutations affected replication they were not as detrimental as
the Fbp mutation R590A. This data suggests that the electrostatic interaction between the
F566 and R590 appears to be of more essential than the hydrophobic pocket for replication.
Completing this experiment in triplicate and determine the growth curve for R687A, W160A,
and 5A7A will need to be continued.
Rolling Circle : Using ssM13 circular DNA we are able to investigate the ability of WT
and our mutant polymerases to replicate DNA alone and its ability to interact with helicase.
The ssM13 is annealed to a primer with a 5’-dt35 tail. The primer is needed for polymerase
to load onto DNA and the 5’ tail allows the helicase to load at the fork junction. Adding just
polymerase to the DNA reveals how the mutations alter the ability to bind to and synthesize
DNA. WT and W160A are able to synthesize the dsM13 DNA product at 2min. The 5A7A
and R590A5A7A complete the circle, then continue around the circle for strand displacement
synthesis. The ability of the 5A7A mutant to perform strand-displacement synthesis was
completely unexpected. Mutating the exonuclease previously killed its ability to perform
DNA synthesis on a short DNA substrate containing a mismatch. The polymerase without
an exonuclease site has a low fidelity and during synthesis of M13 DNA mistakes might
have been made. For every 103 − 105 nucleotides incorporated ∼ 1 mistake is made. If a
mistake was made we hypothesized that the W160A or 5A7A would not be able to repair the
mistake and DNA synthesis would halt. Instead W160A was able to synthesize the dsM13
DNA product like WT and 5A7A was able to perform strand displacement synthesis and
continue around the circular DNA replicating M13. It seems that without the exonuclease
activity the polymerase either did not create any mutations while replicating ssM13, which
is unlikely or the enzyme disregards any mutations and continues synthesizing the DNA. For
future work we would like to study this further by introducing M13 primers that contain
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a mismatch. By adding a primer with a known mismatch we believe that the W160A and
5A7A will not be able to continue synthesis and halt. For replication assays with the Fbp
mutants, we would also like to pursue a competition assay by adding primase-helicase and
titrating in the C-terminal tail peptide. The helicase will compete with the peptide to bind
to the hydrophobic pocket and at a higher concentration of peptide we should see diminished
interaction between the helicase and polymerase. If the helicase cannot interact with the
polymerase DNA synthesis will not occur. If the mutations in the hydrophobic pocket and
the Fbp are essential, then only WT should lose the ability to perform strand displacement
synthesis in the presence of primase-helicase.
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